
Opinion|Videos|July 16, 2024
Treatment Options and Management of Neurofibromatosis Type 1 Related Plexiform Neurofibroma
Author(s)Kaleb H. Yohay, MD
A key opinion leader offers a comprehensive overview of neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN), detailing its symptoms, clinical manifestations, prevalence, and impact on patients' quality of life.
Advertisement
Episodes in this series

- Can you provide an overview of the available management options for NF1-PN and when various options are utilized (observation, surgery, MEK inhibitors, investigational therapies)?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
5-Year Data Support Safety of MRI-Guided AAV2-GDNF Gene Therapy in Advanced Parkinson Disease
2
FDA Grants Fast Track Designation to T-Cell Agent CK0803 for ALS
3
AHA/ASA Issue New Guideline for Adult Stroke Rehabilitation and Recovery
4
FDA Grants Fast Track Designation to Safusidenib for IDH1-Mutant Glioma
5




















